Snowden Capital Advisors LLC Takes $560,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Snowden Capital Advisors LLC acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,089 shares of the company's stock, valued at approximately $560,000.

Other institutional investors have also modified their holdings of the company. Barclays PLC boosted its position in shares of Henry Schein by 6.9% in the third quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after acquiring an additional 18,458 shares during the last quarter. Merit Financial Group LLC boosted its position in shares of Henry Schein by 15.8% in the fourth quarter. Merit Financial Group LLC now owns 23,137 shares of the company's stock worth $1,601,000 after acquiring an additional 3,156 shares during the last quarter. Fifth Third Bancorp boosted its position in shares of Henry Schein by 11.0% in the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company's stock worth $233,000 after acquiring an additional 333 shares during the last quarter. Olstein Capital Management L.P. boosted its position in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after acquiring an additional 16,000 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in shares of Henry Schein in the fourth quarter worth approximately $763,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company's stock.

Henry Schein Stock Performance

HSIC stock opened at $73.13 on Wednesday. The company has a market capitalization of $8.90 billion, a P/E ratio of 30.09, a PEG ratio of 2.13 and a beta of 0.87. The company has a 50-day simple moving average of $67.44 and a 200 day simple moving average of $71.49. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.10 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Piper Sandler decreased their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.